- Home
- POWI vs ZLAB Comparison
POWI vs ZLAB Comparison
Compare POWI & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POWI
- ZLAB
- Stock Information
- Founded
- POWI 1988
- ZLAB 2013
- Country
- POWI United States
- ZLAB China
- Employees
- POWI N/A
- ZLAB N/A
- Industry
- POWI Semiconductors
- ZLAB Biotechnology: Pharmaceutical Preparations
- Sector
- POWI Technology
- ZLAB Health Care
- Exchange
- POWI Nasdaq
- ZLAB Nasdaq
- Market Cap
- POWI 3.2B
- ZLAB 4.3B
- IPO Year
- POWI 1997
- ZLAB 2017
- Fundamental
- Price
- POWI $49.66
- ZLAB $38.57
- Analyst Decision
- POWI Buy
- ZLAB Buy
- Analyst Count
- POWI 6
- ZLAB 5
- Target Price
- POWI $73.33
- ZLAB $54.28
- AVG Volume (30 Days)
- POWI 382.3K
- ZLAB 801.3K
- Earning Date
- POWI 08-06-2025
- ZLAB 08-07-2025
- Dividend Yield
- POWI 1.71%
- ZLAB N/A
- EPS Growth
- POWI N/A
- ZLAB N/A
- EPS
- POWI 0.64
- ZLAB N/A
- Revenue
- POWI $432,814,000.00
- ZLAB $418,326,000.00
- Revenue This Year
- POWI $16.02
- ZLAB $44.07
- Revenue Next Year
- POWI $16.11
- ZLAB $49.13
- P/E Ratio
- POWI $76.59
- ZLAB N/A
- Revenue Growth
- POWI 0.67
- ZLAB 43.72
- 52 Week Low
- POWI $40.78
- ZLAB $16.01
- 52 Week High
- POWI $74.09
- ZLAB $44.34
- Technical
- Relative Strength Index (RSI)
- POWI 31.39
- ZLAB 57.02
- Support Level
- POWI $51.59
- ZLAB $36.51
- Resistance Level
- POWI $53.43
- ZLAB $41.20
- Average True Range (ATR)
- POWI 1.65
- ZLAB 1.18
- MACD
- POWI -0.67
- ZLAB 0.44
- Stochastic Oscillator
- POWI 8.11
- ZLAB 70.43
About POWI Power Integrations Inc.
Power Integrations Inc designs, develops, and markets analog and mixed-signal integrated circuits (ICs) and other electronic components and circuitry used in high-voltage power conversion. Products are used in power converters that convert electricity from a high-voltage source to the type of power required for a specified downstream use. Products are used in electronic products including mobile phones, computing and networking equipment, appliances, electronic utility meters, battery-powered tools, industrial controls, home automation, or Internet of Things applications such as networked thermostats, power strips, and security devices. Geographically, the company generates maximum revenue from China and Hong Kong.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.